Fish-Farming Industry Is Ripe for Disruption
Genomics is not limited to DNA-medicine. It’s also a tech disruptor in other industries like fish farming, and that offers some profitable opportunities.
Read More
Author: Adam O'Dell
Aging Boomers: A Perfect Tailwind for Genomics Stocks
Aging baby boomers are a decades-long tailwind for genomics stocks as scientists develop DNA-based medicine to fight prolific diseases.
Biotech Barbell: The Best Way to Invest in a “Risky” Sector
Investing in a segment like biotech doesn’t have to feel risky. The “barbell” strategy creates a balance between high- and low-risk assets.
Bigger Than the Internet: DNA Will Lead the Next Stock Market Wave
The DNA revolution is here, and I think it has the potential to be more impactful than the internet across multiple stock sectors.
A Biotech Co.’s Journey from Small- to Mid-Cap — and Beyond
A stock’s size factor relates to its market capitalization, and it explains in part how smaller companies can lead to huge stock market gains.
Watchlist
